⏳ Fetching live dividend data...
Home › Calculator › PSTI Dividend Calculator 2026
Pluristem Therapeutics Inc. · NASDAQ
Price: $1.00 · Annual div: None · Frequency: — · Payout ratio: N/A · Ex-div: —
PSTI is not a dividend-focused stock
PSTI pays a very low or no dividend (Yield: 0.00%). This calculator is designed for income-producing assets. If your goal is passive income and compounding, you might want to look at these popular alternatives:
Pluristem Therapeutics Inc. (PSTI) does not currently pay a regular dividend in our data, so its dividend yield is 0%.
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
Pluristem Therapeutics Inc., an Israeli biotechnology firm founded in 2001 and based in Haifa, specializes in the discovery, advancement, clinical assessment, and production of innovative cell-based therapeutic products. The company's primary focus is on addressing a spectrum of severe medical conditions, including those related to reduced blood flow (ischemia), inflammation, blood disorders, and autoimmune dysfunctions, using its proprietary technologies. A cornerstone of their product pipeline involves placental expanded (PLX) based cell therapies. Their leading investigational drug, PLX-PAD, is currently undergoing evaluation in several clinical studies: it's in a late-stage (Phase III) trial to aid recovery after hip fracture surgery, a mid-stage (Phase II) trial for treating acute respiratory distress syndrome linked to COVID-19, and an early-to-mid-stage (Phase I/II) trial for severe graft-versus-host disease that has not responded to steroid treatment. Another significant product, PLX-R18, has successfully completed its initial Phase I clinical trial for individuals experiencing incomplete blood cell recovery following hematopoietic cell transplantation. Additionally, Pluristem is conducting preclinical animal studies to investigate PLX-R18's potential for treating acute radiation syndrome. The company also engages in various strategic collaborations: it holds a licensing agreement that facilitates PLX-PAD clinical trials in South Korea; participates in the nTRACK project, which explores labeling stem cells with gold nanoparticles; and has a unique partnership with NASA's Ames Research Center to assess how PLX cell therapies might prevent or alleviate medical issues encountered during space missions.
No. Pluristem Therapeutics Inc. (PSTI) has not paid a regular dividend in the last 12 months in our data, so its dividend yield is 0% and it produces no dividend income.
Dividend ETFs such as SCHD, VYM or JEPI pay regular income. Open their DRIP calculators to see what $10,000 would earn per month and how reinvesting grows it.
A DRIP reinvests dividends into new shares. PSTI has no regular dividend in our data, so there is nothing to reinvest.
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open PSTI position with:
Real after-tax yield depends on where you live and how you hold PSTI.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK ISA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK Taxable | 8.75% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 TFSA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 CA Taxable | 25% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 Super (pension) | 15% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 AU Taxable | 30% | 0.00% | -2.80% | $0 / yr |
| 🇩🇪 DE Taxable | 26.375% | 0.00% | -2.80% | $0 / yr |
| 🇫🇷 FR Taxable | 30% | 0.00% | -2.80% | $0 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
No dividend data available for this ticker.
Based on current dividend of $0.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
PSTI pays quarterly — 4 times per year. Ex-div: —.
How PSTI compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for PSTI sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Buy | 2022-02-10 | 80,616 | $1.80 | $145.1K | ||
| Sale | 2021-05-26 | 122,663 | $3.68 | $451.4K | ||
| Sale | 2021-05-26 | 22,015 | $3.69 | $81.2K | ||
| Sale | 2021-05-27 | 71,775 | $3.69 | $264.9K | ||
| Sale | 2021-05-27 | 24,110 | $3.69 | $89.0K | ||
| Sale | 2021-05-28 | 70,007 | $3.72 | $260.4K | ||
| Sale | 2021-05-28 | 45,000 | $3.72 | $167.4K | ||
| Sale | 2021-05-21 | 69,838 | $3.98 | $278.0K | ||
| Sale | 2021-05-24 | 79,300 | $3.83 | $303.7K | ||
| Sale | 2021-05-25 | 261,238 | $3.84 | $1.00M |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Compare PSTI with peers: PSTI vs ALVR · PSTI vs CERC · PSTI vs EYEN
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the PSTI dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Pluristem Therapeutics Inc. (PSTI) is currently trading at $1.00, trading near its 52-week low. It does not currently pay a regular dividend.
Pluristem Therapeutics Inc. (PSTI) is a healthcare stock trading at $1.00. It does not currently pay a regular dividend in our data, so it produces no dividend income and DRIP reinvestment does not apply. Investors seeking income often look at dividend ETFs such as SCHD, VYM or JEPI instead.
Auto-generated from live market data. For educational purposes only — not financial advice.
If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.
⏱️ Takes 30 seconds · No signup · Free forever